InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Net Income 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2021 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- InMed Pharmaceuticals Inc. net income for the quarter ending December 31, 2025 was -2.0 M, a 21.23% decrease year-over-year.
- InMed Pharmaceuticals Inc. net income for the twelve months ending December 31, 2025 was -8.5 M, a 13.96% increase year-over-year.
- InMed Pharmaceuticals Inc. annual net income for 2025 was -8.2 M, a 6.34% increase from 2024.
- InMed Pharmaceuticals Inc. annual net income for 2024 was -7.7 M, a 3.42% decrease from 2023.
- InMed Pharmaceuticals Inc. annual net income for 2023 was -7.9 M, a 57.27% decrease from 2022.
- InMed Pharmaceuticals Inc. annual net income for 2022 was -18.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
InMed Pharmaceuticals Inc. Net Income — FAQ
InMed Pharmaceuticals Inc. (INM) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is InMed Pharmaceuticals Inc.'s net income?
InMed Pharmaceuticals Inc. (INM) reported net income of -$8M for fiscal 2025.
Where can I see INM's net income history?
The chart and table above show InMed Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.